Literature DB >> 18691496

Factor VIIa binding to endothelial cell protein C receptor.

L Vijaya Mohan Rao1, Usha R Pendurthi.   

Abstract

Recent studies have shown that factor VIIa (FVIIa) binds specifically to endothelial protein C receptor (EPCR), a known cellular receptor for protein C and activated protein C, on the endothelium. The formation of FVIIa:EPCR complexes neither supports the activation of coagulation nor modulates tissue factor-initiated coagulation. However, FVIIa interaction with EPCR, particularly at pharmacological concentrations of FVIIa, may impair EPCR-dependent protein C activation and activated protein C-mediated cell signaling by competing directly with them for binding to EPCR. FVIIa binding to EPCR may also contribute to FVIIa clearance. This review summarizes recent data on FVIIa interaction with EPCR and discusses potential physiological significance and consequences of the interaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691496      PMCID: PMC2591929          DOI: 10.1016/S0049-3848(08)70009-4

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  18 in total

1.  Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow.

Authors:  Alejandro B Balazs; Attila J Fabian; Charles T Esmon; Richard C Mulligan
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

2.  Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium.

Authors:  Samit Ghosh; Usha R Pendurthi; Anne Steinoe; Charles T Esmon; L Vijaya Mohan Rao
Journal:  J Biol Chem       Date:  2007-02-27       Impact factor: 5.157

3.  Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway.

Authors:  Z Laszik; A Mitro; F B Taylor; G Ferrell; C T Esmon
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

4.  The endothelial cell protein C receptor. Inhibition of activated protein C anticoagulant function without modulation of reaction with proteinase inhibitors.

Authors:  L M Regan; D J Stearns-Kurosawa; S Kurosawa; J Mollica; K Fukudome; C T Esmon
Journal:  J Biol Chem       Date:  1996-07-19       Impact factor: 5.157

5.  Multifunctional specificity of the protein C/activated protein C Gla domain.

Authors:  Roger J S Preston; Eva Ajzner; Cristina Razzari; Stalo Karageorgi; Sonia Dua; Björn Dahlbäck; David A Lane
Journal:  J Biol Chem       Date:  2006-07-25       Impact factor: 5.157

6.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.

Authors:  Clemens Feistritzer; Matthias Riewald
Journal:  Blood       Date:  2004-12-30       Impact factor: 22.113

7.  The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex.

Authors:  D J Stearns-Kurosawa; S Kurosawa; J S Mollica; G L Ferrell; C T Esmon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells.

Authors:  Jong-Sup Bae; Likui Yang; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Blood       Date:  2007-09-06       Impact factor: 22.113

Review 9.  Structure and functions of the endothelial cell protein C receptor.

Authors:  Charles T Esmon
Journal:  Crit Care Med       Date:  2004-05       Impact factor: 7.598

10.  Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity.

Authors:  J López-Sagaseta; R Montes; C Puy; N Díez; K Fukudome; J Hermida
Journal:  J Thromb Haemost       Date:  2007-09       Impact factor: 5.824

View more
  2 in total

1.  Silencing CX3CR1 production modulates the interaction between dendritic and endothelial cells.

Authors:  Xiaoyan Liu; Guohong Lu; Jinfang Shen
Journal:  Mol Biol Rep       Date:  2010-04-03       Impact factor: 2.316

2.  Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patients.

Authors:  H Agersø; D F Brophy; H Pelzer; E J Martin; M Carr; U Hedner; M Ezban
Journal:  J Thromb Haemost       Date:  2011-02       Impact factor: 5.824

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.